BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6820113)

  • 21. Etidronate disodium in the treatment of Paget's disease of bone.
    Krane SM
    Ann Intern Med; 1982 May; 96(5):619-25. PubMed ID: 6280538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
    D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
    Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
    [No Abstract]   [Full Text] [Related]  

  • 23. APD in Paget's disease of bone. Role of the mononuclear phagocyte system?
    Bijvoet OL; Frijlink WB; Jie K; van der Linden H; Meijer CJ; Mulder H; van Paassen HC; Reitsma PH; te Velde J; de Vries E; van der Wey JP
    Arthritis Rheum; 1980 Oct; 23(10):1193-204. PubMed ID: 6448605
    [No Abstract]   [Full Text] [Related]  

  • 24. 'Breaking the back' of Paget's bone disease.
    Ryan WG
    Arch Intern Med; 1989 Dec; 149(12):2639. PubMed ID: 2531996
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
    Nuti R; Turchetti V; Righi G; Vattimo A
    Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Paget's disease of bone.
    Melick RA
    Med J Aust; 1985 Oct; 143(9):394-7. PubMed ID: 2932626
    [No Abstract]   [Full Text] [Related]  

  • 27. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 28. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ; Gunasekera RD
    Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy.
    Siris ES; Canfield RE; Jacobs TP; Stoddart KE; Spector PJ
    Metab Bone Dis Relat Res; 1981; 3(4-5):301-8. PubMed ID: 6820111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of antibodies to synthetic human calcitonin during treatment of Paget's disease.
    Dietrich FM; Fischer JA; Bijvoet OL
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):468-76. PubMed ID: 517048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology.
    Basle MF; Rebel A; Renier JC; Audran M; Filmon R; Malkani K
    Clin Orthop Relat Res; 1984 Apr; (184):281-8. PubMed ID: 6423333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of Paget's disease of bone with diphosphonates and calcitonin].
    Ziegler R; Holz G; Minne H; Delling G
    Verh Dtsch Ges Inn Med; 1978; (84):1122-5. PubMed ID: 741902
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
    Dewis P; Prasad BK; Anderson DC; Willets S
    Ann Rheum Dis; 1985 Jan; 44(1):34-8. PubMed ID: 3918513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
    Sieghart S
    Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procollagen-III peptide serum levels in Paget's disease of the bone.
    Wilder-Smith CH; Raue F; Holz-Gottswinter G; Ziegler R
    Klin Wochenschr; 1987 Feb; 65(4):174-8. PubMed ID: 3104661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paget's disease of bone--current thinking and management.
    Hughes S; Peel-White AL; Peterson CK
    J Manipulative Physiol Ther; 1992 May; 15(4):242-9. PubMed ID: 1321871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paget's disease of bone.
    Krane SM
    Clin Orthop Relat Res; 1977; (127):24-36. PubMed ID: 410574
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of Paget's disease of bone with bisphosphonates.
    Mazières B
    Rev Rhum Engl Ed; 1995 Feb; 62(2):72-8. PubMed ID: 7600075
    [No Abstract]   [Full Text] [Related]  

  • 39. [Etidronic acid therapy in Paget's disease of bone].
    Holz G; Delling G; Ziegler R
    Dtsch Med Wochenschr; 1983 Dec; 108(51-52):1954-8. PubMed ID: 6418505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical assessment of acute and chronic treatment of Paget's bone disease with calcitonin and calcium with and without biphosphonate.
    Rico H; Hernández ER; Younes M; Hernández D; Espinós D
    Bone; 1988; 9(1):63-6. PubMed ID: 3132191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.